The production of the Russian vaccine against coronavirus Sputnik V in the European Union is possible if the drug is approved by the European Medicines Agency (EMA). Such a condition was called by the deputy official representative of the Cabinet of Ministers of the Federal Republic of Germany Ulrike Demmer, her words are quoted by TASS.
“If we talk about the production capacity in Europe for the Russian vaccine, this is possible only if the EMA allows this drug,” Demmer said at a briefing on Wednesday, December 6. She did not specify whether such a request was received by the European regulator.
Earlier, the European Medicines Agency approved the use of Moderna's coronavirus vaccine in the European Union. Prior to that, on December 21, the European Union authorized the use of the Pfizer vaccine, and on December 27, vaccination began in the countries of the union.
There are currently several COVID-19 vaccines in the world. So, in Russia two vaccines are registered: “Sputnik V” and “EpiVacCorona”. On December 5, Moscow started vaccination against coronavirus with Sputnik V. The US also began inoculating the population with drugs from Pfizer / BioNTech and Moderna. Pfizer and AstraZeneca vaccines have been approved in the UK.
